About this trial
The Minos™ Abdominal Aortic Stent-Graft and Delivery System is a medical device designed to treat abdominal aortic aneurysms using a minimally invasive procedure. The device is placed inside the aorta through blood vessels, usually accessed through small incisions in the groin. The goal of this observational study is to collect short-, medium- to long-term safety and performance data of the Minos™ stent-graft in everyday medical practice (real-world settings). The aim is to study about 200 patients worldwide and at least 30 patients in European hospitals.
Eligibility criteria
Qualifiers
Diagnosis of infrarenal abdominal aortic aneurysm
Plan to treat with Minos Abdominal Aortic Stent-Graft and Delivery System
Voluntary participation and completion of Informed Consent Form, with willingness to participate in follow-up to 5 years post-procedure
Disqualifiers
Severe stenosis or calcification near the aneurysm, leading to difficulty in achieving apposition of vessel wall and stent graft.
Difficult access due to severe stenosis or tortuosity in the iliac artery or femoral artery.
Subjects with ruptured aneurysm or acute aneurysm.
Subjects with an infectious aneurysm.
Trial design
Treatments tested in this trial
- Implantation with Minos Stent graft